Home
electronic Investigator Global Assessment of Atopic Dermatitis
eIGA for AD
Atopic dermatitis assessment made
easy and quick
What is the eIGA for atopic dermatitis?
The Investigator Global Assessment (IGA) is a 6-point scoring system used to assess the severity of atopic dermatitis. The terms physician or investigator global assessment (IGA) may be used interchangeably. IGA is assessed via the intensity of the erythema and papulation/infiltration and gives a general impression of severity or improvement of AD over time. The IGA was originally developed to assess the disease severity within clinical trials and is one of the standard parameters collected to assess treatment success. In recent time, IGA is more commonly used in clinical practice to guide treatment decisions for physicians and document the impact of the clinical treatment over time.
Validation of questionnaire
paper version: yes digital version: no
How to use the eIGA for atopic dermatitis
The IGA should only be used by trained physicians. IGA for AD is assessed by the intensity of the erythema and papulation/infiltration and ranges from clear (0), almost clear (1), mild (2), moderate (3), to severe (4) and very severe disease (6). Each severity grade is distinctly defined by a relevant morphologic description to ensure comparability of IGA scores between health care providers and over time.
The eIGA for atopic dermatitis
The eIGA provides a quick and easy objective assessment of atopic dermatitis from the perspective of the treating physician using defined criteria.
The following versions of the eIGA for AD are available
Features
USER-FRIENDLY
eIGA is straightforward to use, thanks to the clear morphological description of the severity states.
SEVERITY MONITORING
Save your time with eIGA. In only few minutes you can get your IGA score without doing any calculations.
ENVIRONMENTALLY FRIENDY
Take care of the environment and save your patient data on the online platform or as PDF files for yourself and your physicians.
ACCURATE
The eIGA is recommended by international guideline associations for an accurate measure of severity of the dermatological disease.
ACCESSIBLE FROM ALL DEVICES
With DermaValue, your eIGA is always just a few clicks away. The application is available for PCs, tablets, smartphones, and other devices.
MULTILINGUAL
The IGA is available in various languages, so choose the one you prefer and forget about language barriers.
References
Minimal Clinically Important Difference (MCID):
Silverberg, J. I., Lei, D., Yousaf, M., Janmohamed, S. R., Vakharia, P. P., Chopra, R., Chavda, R., Gabriel, S., Patel, K. R., Singam, V., Kantor, R., & Hsu, D. Y. (2021). Measurement properties of the product of investigator's global assessment and body surface area in children and adults with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(1), 180–187. https://doi.org/10.1111/jdv.16846
Our other tools
Our partners
